Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 28.70 is 27% below its 5-year average of 39.06, near the low end of its 5-year range (15.83–140.46).
As of the fiscal period ended Tuesday, June 30, 2026. 0.14% below its 12-month average of 28.73.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 28.70.
QUICK RATIO (ACID-TEST)
28.70
QUICK RATIO (ACID-TEST) AVG TTM
28.73
QUICK RATIO (ACID-TEST) AVG 3Y
24.98
QUICK RATIO (ACID-TEST) AVG 5Y
39.06
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-0.14%
CURRENT VS 3Y AVG
+14.89%
CURRENT VS 5Y AVG
-26.53%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+756.58%
vs the sector median at left
GH Research PLC
Market Cap
$1.47B
Quick Ratio (Acid-Test)
28.70
TTM Avg
28.73
3Y Avg
24.98
5Y Avg
39.06
Market Cap
$1.47B
Quick Ratio (Acid-Test)
15.72
TTM Avg
30.76
3Y Avg
24.36
5Y Avg
24.36
Market Cap
$1.49B
Quick Ratio (Acid-Test)
1.27
TTM Avg
1.26
3Y Avg
1.48
5Y Avg
1.54
Market Cap
$1.46B
Quick Ratio (Acid-Test)
18.31
TTM Avg
12.63
3Y Avg
8.12
5Y Avg
8.12
Market Cap
$1.44B
Quick Ratio (Acid-Test)
2.94
TTM Avg
3.04
3Y Avg
2.84
5Y Avg
2.90
Market Cap
$1.44B
Quick Ratio (Acid-Test)
1.56
TTM Avg
2.29
3Y Avg
2.59
5Y Avg
3.62
Market Cap
$1.51B
Quick Ratio (Acid-Test)
1.30
TTM Avg
1.23
3Y Avg
1.77
5Y Avg
3.05
Market Cap
$1.53B
Quick Ratio (Acid-Test)
4.96
TTM Avg
2.73
3Y Avg
2.17
5Y Avg
2.82
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GH Research PLC (GHRS) | $1.47B | 28.70 | 28.73 | 24.98 | 39.06 |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.47B | 15.72 | 30.76 | 24.36 | 24.36 |
| Phibro Animal Health Corporation (PAHC)vs › | $1.49B | 1.27 | 1.26 | 1.48 | 1.54 |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | 18.31 | 12.63 | 8.12 | 8.12 |
| Certara, Inc. (CERT)vs › | $1.45B | 2.55 | 2.09 | 2.53 | 2.95 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.44B | 2.94 | 3.04 | 2.84 | 2.90 |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.44B | 1.56 | 2.29 | 2.59 | 3.62 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 1.30 | 1.23 | 1.77 | 3.05 |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 4.96 | 2.73 | 2.17 | 2.82 |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 5.61 | 9.29 | 11.65 | 16.84 |
Quick Ratio
28.70
Excludes inventory
Current Ratio
28.70
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 28.70 |
| 2026-03-31 | 23.04 |
| 2025-12-31 | 34.13 |
| 2025-09-30 | 28.32 |
| 2025-06-30 | 29.49 |
| 2025-03-31 | 29.71 |
| 2024-12-31 | 17.23 |
| 2024-09-30 | 15.83 |
| 2024-06-30 | 19.60 |
| 2024-03-31 | 22.06 |
| 2023-12-31 | 24.49 |
| 2023-09-30 | 26.74 |
| 2023-06-30 | 25.38 |
| 2023-03-31 | 24.81 |
| 2022-12-31 | 37.07 |
| 2022-09-30 | 76.82 |
| 2022-06-30 | 86.02 |
| 2022-03-31 | 67.26 |
| 2021-12-31 | 100.70 |
| 2021-09-30 | 140.46 |
| 2021-06-30 | 63.76 |
| 2021-03-31 | 4.46 |
| 2020-12-31 | 24.03 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
